Webcast

Home/Webcast

Innovative Approach in GIST Research in the Era of Precision Medicine

Columbia University Medical Center, New York-Presbyterian and the Life Raft Group have entered into a collaborative effort to advance research to find a cure for GIST using a novel therapeutic approach and patient-driven data. [...]

By |2018-10-30T09:13:45-04:00July 12th, 2017|Video, Webcast|

GIST Patient Community Update on BLU-285 Clinical Program

Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an [...]

By |2018-10-30T09:14:36-04:00July 6th, 2017|Clinical Trials, Webcast|

Examining Kidney Toxicities of Sunitinib and Imatinib in Long-Term GIST Therapy

On September 19, 2016 the Life Raft Group was pleased to have Dr. Benjamin D. Humphreys, Chief of the Division of Nephrology at Washington University in St. Louis School of Medicine, share his knowledge [...]

By |2019-11-26T11:49:16-05:00September 19th, 2016|GIST Education, Gleevec, Sutent, Webcast|

Webcast Provides Perspective on Generic Imatinib

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”

By |2019-11-26T11:34:02-05:00April 8th, 2016|Generics, GIST Education, Newsletter, Webcast|